{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:23:42Z","timestamp":1782386622210,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.vascn.2025.107742","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T23:26:51Z","timestamp":1745450811000},"page":"107742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The statistical and pharmacological sensitivity of nonclinical QTc analysis comparing jacketed telemetry and multilead snapshot recording in the same dogs"],"prefix":"10.1016","volume":"133","author":[{"given":"Matthew M.","family":"Abernathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek D.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek J.","family":"Leishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2025.107742_bb0005","series-title":"ICH S9: Nonclinical evaluation for anticancer pharmaceuticals","author":"Anonymous","year":"2009"},{"key":"10.1016\/j.vascn.2025.107742_bb0010","series-title":"M3(R2) non-clinical safety studies for conduct of human clinical trials for pharmaceuticals","author":"Anonymous","year":"2009"},{"key":"10.1016\/j.vascn.2025.107742_bb0015","series-title":"ICH E14\/S7B implementation working group - Clinical and nonclinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential. Questions and answers","author":"Anonymous","year":"2022"},{"key":"10.1016\/j.vascn.2025.107742_bb0020","series-title":"ICH_E14-S7B training material examples supplemental file 2022_0331.pdf","author":"Anonymous","year":"2022"},{"issue":"10","key":"10.1016\/j.vascn.2025.107742_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70046","article-title":"A \u201cone-step\u201d approach to heart rate correction and statistical analysis applied to conscious dog QTc studies","volume":"17","author":"Best","year":"2024","journal-title":"Clinical and Translational Science"},{"key":"10.1016\/j.vascn.2025.107742_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.3283","article-title":"Results from a joined prospective study to evaluate the sensitivity of the in vivo dog QT assay in line with the ICH E14\/S7B Q&A best practices","author":"B\u00e9tat","year":"2024","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2025.107742_bb0035","series-title":"Experimental design","author":"Cochran","year":"1957"},{"issue":"11","key":"10.1016\/j.vascn.2025.107742_bb0040","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/jcph.2309","article-title":"The new S7B\/E14 Q&A document provides additional opportunities to replace the thorough QT study","volume":"63","author":"Darpo","year":"2023","journal-title":"Journal of Clinical Pharmacology"},{"issue":"Suppl B","key":"10.1016\/j.vascn.2025.107742_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/43.suppl_2.91","article-title":"Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone","volume":"43","author":"von Keutz","year":"1999","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.vascn.2025.107742_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2023.107299","article-title":"Comparing the sensitivity of cross-over and parallel study designs for QTc assessment: An analysis based on a single large study of moxifloxacin in 48 nonhuman primates","author":"Leishman","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.107742_bb0055","article-title":"Demonstrating the statistical and pharmacological sensitivity of nonclinical QTc analysis using a dofetilide dose-response in nonhuman primates","author":"Leishman","year":"2024","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"11","key":"10.1016\/j.vascn.2025.107742_bb0060","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1111\/cts.13625","article-title":"The \u201cone-step\u201d approach for QT analysis increases the sensitivity of nonclinical QTc analysis","volume":"16","author":"Leishman","year":"2023","journal-title":"Clinical and Translational Science"},{"issue":"5","key":"10.1016\/j.vascn.2025.107742_bb0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1538\/expanim.51.465","article-title":"Rate-correction technique for QT interval in long-term telemetry ECG recording in beagle dogs","volume":"51","author":"Miyazaki","year":"2002","journal-title":"Experimental Animals"},{"key":"10.1016\/j.vascn.2025.107742_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2024.107537","article-title":"Comparison of electrocardiogram and blood pressure recording methods in non-rodent toxicology studies: A retrospective analysis","volume":"128","author":"Pawluk","year":"2024","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2025.107742_bb0080","series-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2022"},{"key":"10.1016\/j.vascn.2025.107742_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2023.107270","article-title":"Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14\/S7B Q&As","author":"Rossman","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"4","key":"10.1016\/j.vascn.2025.107742_bb0090","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/00031305.1980.10483031","article-title":"Population marginal means in the linear model: An alternative to least squares means","volume":"34","author":"Searle","year":"1980","journal-title":"The American Statistician"},{"key":"10.1016\/j.vascn.2025.107742_bb0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/43.suppl_2.69","article-title":"Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: A comparison in humans and other mammalian species","volume":"43","author":"Siefert","year":"1999","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1016\/j.vascn.2025.107742_bb0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/toxsci\/45.2.247","article-title":"The heart rate-corrected QT interval of conscious beagle dogs: A formula based on analysis of covariance","volume":"45","author":"Spence","year":"1998","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2025.107742_bb0105","article-title":"Translational models and tools to reduce clinical trials and improve regulatory decision making for QTc and proarrhythmia risk (ICH E14\/S7B updates)","author":"Strauss","year":"2020","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.vascn.2025.107742_bb0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0160-5402(89)90015-6","article-title":"An improved method to correct the QT interval of the electrocardiogram for changes in heart rate","volume":"22","author":"Van de Water","year":"1989","journal-title":"Journal of Pharmacological Methods"},{"key":"10.1016\/j.vascn.2025.107742_bb0115","article-title":"Time for a fully integrated nonclinical-clinical risk assessment to streamline QT prolongation liability determinations: A pharma industry perspective","author":"Vargas","year":"2020","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2025.107742_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2023.107265","article-title":"Improving the in vivo QTc assay: The value of implementing best practices to support an integrated nonclinical-clinical QTc risk assessment and TQT substitute","volume":"121","author":"Vargas","year":"2023","journal-title":"Journal of Pharmacological and Toxicological Methods"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871925001625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871925001625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T21:02:42Z","timestamp":1746824562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871925001625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":23,"alternative-id":["S1056871925001625"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2025.107742","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The statistical and pharmacological sensitivity of nonclinical QTc analysis comparing jacketed telemetry and multilead snapshot recording in the same dogs","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2025.107742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107742"}}